Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Timed-Sequential Induction in CBF-AML

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 60				Other				P060504 EudraCT N° : 2006-005163-26, NCT00428558

First Published: 10/23/2007


2.		Phase I/II Study of Gemcitabine Hydrochloride, Paclitaxel, Ifosfamide, and Cisplatin as Salvage Chemotherapy in Patients With Progressive or Relapsed Metastatic Germ Cell Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				16 to 60				Other				USCTU-UR1002-GEM-TIP UR1002-Gem-TIP, EU-20769, EUDRACT-2004-004804-19, NCT00551122


3.		Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				60 to 80				Other				C-008 NCT00529880

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute